Clague, J. (2004) Gentechnik und Gemeinwohl. Zeitschrift für Medizinische Ethik, 50(2), pp. 165-181.
Full text not currently available from Enlighten.
Publisher's URL: http://195.30.246.247/vs1/userseite/start.asp?par=8&heft_jahr=2004&heftnr=2
Abstract
The chief moral justification for investment in genetic technologies is on the basis of their medical benefit to humanity. However, the humanitarian goal of medicine has come to play a less prominent role in the bioethical literature and medical codes over the course of the twentieth-century. Instead, the promotion of benefit is more frequently discussed in the context of a physician’s duty of beneficence to his or her patient. This study argues that the economic and social questions that emerge in ethical discussions of genetics are inadequately served by the more restrictive language of beneficence. The concept of the common good (or public welfare) offers a more versatile means to discuss the social questions that genetics poses.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Clague, Ms Julie |
| Authors: | Clague, J. |
| College/School: | College of Arts & Humanities > School of Critical Studies > Theology and Religious Studies |
| Journal Name: | Zeitschrift für Medizinische Ethik |
| Publisher: | Schwabenverlag AG |
| ISSN: | 0403-3884 |
| Related URLs: |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details